Oncternal Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Oncternal Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $-2.86 | $-3.19 | 10.3 % |
Jun 2024 | 2024-08-08 | $-2.89 | $-3.10 | 6.77 % |
Mar 2024 | 2024-05-09 | $-2.83 | $-2.88 | 1.74 % |
Dec 2023 | 2024-03-07 | $-3.11 | $-3.07 | -1.30 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $494.00K | $140.00K | 252.9 % |
Jun 2024 | 2024-08-08 | $801.00K | $240.00K | 233.8 % |
Mar 2024 | 2024-05-09 | $569.00K | $180.00K | 216.1 % |
Dec 2023 | 2024-03-07 | $297.00K | $140.00K | 112.1 % |
Oncternal Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3.
Oncternal Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3 and the Actual EPS was $-2.86, which beat the estimate of $-3.19.
Oncternal Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.